Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAITH: Fondaparinux in Thrombocytopenic Inpatients
NCT01727401Phase 4Terminated
- Sponsor
- Università degli Studi Gabriele d'Annunzio Chieti e Pescara
- Start
- Nov 2012
- Primary completion
- Jul 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of fondaparinux in venous thromboembolism (VTE), sponsored by Università degli Studi Gabriele d'Annunzio Chieti e Pescara. Started Nov 2012; status: terminated.
02
Drugs
fondaparinux
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01727401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01727401.